Mouse interferon a@? exerted a similar anti-tumor effect in DBA/2 mice injected i.p. with Friend erythroleukemia cells (FLC) either sensitive or resistant to interferon as determined by both in vitro and in vivo assays. Using this tumor system we attempted to define optimal treatment regimens for in
Anti-tumor effects of interferon in mice injected with interferonsensitive and interferon-resistant friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases
✍ Scribed by Ion Gresser; Chantal Maury; Filippo Belardelli
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 661 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
DBAl2 mice were injected i.v. with IFN alp-resistant 3C I 8 Friend erythroleukemia cells (FLC) which metastasize to the liver and spleen. IFN d p treatment of FLC-injected mice increased their survival time and these mice developed a resistance to a second challenge with FLC. The efficacy of IFN d p
## Abstract Administration of highly purified interferon to DA/2 mice inhibited the growth of interferon‐sensitive or interferon‐resistant Friend erythroleukemia cells implanted subcutaneously. Injection of interferon at the site of tumor inoculation was more effective than injection of interferon
respectively. Solid arrows indicate easily visible foci of tumor cells against background of normal hepatic parenchyma. In (c) the hepatic parenchyma is totally replaced by tumor except for small island of normal liver indicated by an open arrow. Hematoxylin and eosin. X 20.